Published: 10 July 2017
In The Lancet Psychiatry, Schoeler and colleagues present a study describing the mediating effect of medication adherence on the association between continued cannabis use and relapse risk in patients with first-episode psychosis. They have previously reported a relapse rate of 36% in this patient group over a 2-year period.
Acknowledging the potential risk of psychosis relapse related to the high proportion of patients continuing cannabis use after the onset of psychosis, the current study1 investigates the same patient group consisting of 245 patients, obtaining retrospective data on active cannabis use and medication adherence shortly after illness onset, as well as risk of relapse at 2-year follow-up. The authors find that relapse of psychosis associated with continued cannabis use is partly mediated through non-adherence to prescribed antipsychotic medication.
It is well established that cannabis use increases the risk of schizophrenia, not only from the early Swedish conscript studies but also from studies on people who use sinsemilla in London, UK, showing that high potency cannabis increases the risk of schizophrenia. Twin studies from Norway have shown that cannabis increases the risk of psychosis, even when controlling for genetic factors. There has been discussion on the direction of the association, as none of these studies can rule out reverse causality, but it seems reasonable to conclude that cannabis is one of many stressors that can precipitate schizophrenia, at least in susceptible individuals.
“What do you want, what do you hate, what’s going to turn you off so I can’t ask you for money?”
This was the question the nation’s top pot lobbyist recently posed to tobacco executives in Michigan, where his lobbying group has drafted language for a recreational marijuana legalization law and is now collecting signatures to place it on the state’s 2018 ballot.
That Rob Kampia, Executive Director of the Marijuana Policy Project (MPP), went on-the-record to admit he asked this of Michigan tobacco companies is both alarming and contemptible. MPP is the lead special interest group responsible for funding and organizing every state-based marijuana commercialization campaign in the U.S. Kampia’s shameless solicitation for contributions from the tobacco industry should send chills down the spine of every American who remembers our painful national experience with Big Tobacco.
The nascent marijuana industry, which has been profiting off of high-potency commercial products, is not only following in Big Tobacco’s footsteps, but now openly admitting to taking money from them.
Make no mistake, the marijuana industry is laying the groundwork to take center stage as Big Tobacco 2.0. Tobacco companies have been eyeing marijuana as the next big addictive enterprise since the 1970’s, and now they’re getting in on this cash cow in the ultimate quid pro quo: taking money in return for shaping the language of today’s marijuana legalization initiatives
One in 5 adolescents at risk of tobacco dependency, harmful alcohol consumption and illicit drug use
Date: June 7, 2017
Source: University of Bristol
Summary: Researchers have found regular and occasional cannabis use as a teen is associated with a greater risk of other illicit drug taking in early adulthood. The study also found cannabis use was associated with harmful drinking and smoking.
2 June 2017
The teenager's father is backing Lord Monson's call for skunk to be reclassified
Credit:Matthew Fearn/PA wire
Ateenage rugby player cut off his own penis and stabbed his mother while high on skunk, his father has revealed, as he called for the drug to be reclassified.
The father, named only as Nick because he wants to remain anonymous as his son is rebuilding his life, is backing Lord Nicholas Monson's campaign to have skunk reclassified from a class B to a class A drug and for the traditional weaker form of cannabis to be decriminalised.
Lord Monson launched his call following the suicide of his 21-year-old son Rupert, who was addicted to skunk.
What was going through Salman Abedi’s mind when he made that journey to Manchester Arena on Monday night? How does someone do something so unspeakably evil as to slaughter and grievously injure innocent young children in this way?
Was he a psychopath? Was he evil? I do not know the answer but I do know, as the Mail reports today, that according to his friends Abedi was a frequent and heavy cannabis smoker.
Studies into the personality type of would-be jihadi terrorists have found some recurring themes that make an individual ‘ripe’ for radicalisation. They tend to feel angry, alienated or disenfranchised.
There is also a strong sense of victimhood and that they are fighting for a social injustice.
They have a poor sense of identity and tend to be ‘adolescent’ and petulant. This kind of personality type, combined with cannabis use, surely produces an individual more receptive to the kind of hate-filled rhetoric peddled by radical Islamists.
For too long, we have ignored the terrible toll of this drug. Too many people have dismissed cannabis as harmless — something to help you relax and chill — and that an individual should be free to buy and use as they choose.
Now, more than ever, we need to wake up to a pernicious substance that ruins not just the lives of those that take it, but countless others around them in ways we might never have imagined.